Background/Aims: Induction of oxidative stress and reactive oxygen species (ROS) mediatedapoptosis have been utilized as effective strategies in anticancer therapy. Macranthoidin B (MB) is a potent inducer of ROS-mediated apoptosis in cancer, but its mechanism of action is poorly understood. Method: Superoxide production with MB exposure in colorectal cancer (CRC) cells was measured using lucigenin chemiluminescence and real-time PCR. MB's inhibitory effect on proliferation and viability of CRC cells was determined by proliferation assays. MB's effect on apoptosis of CRC cells was determined by Western blotting and annexin V-FITC/PI staining. MB's effect on the growth of CRC xenografts in mice was assessed. An established metabolomics profiling platform combining ultra-performance liquid chromatography-tandem mass spectrometry (LC-MS) with gas chromatography-mass spectrometry (GC-MS) was performed to determine MB's effect on total metabolite variation in CRC cells. Results: We found that MB increases ROS generation via modulating key metabolic pathways. Using metabolomics profiling platform combining LC-MS with GC-MS, a total of 236 metabolites were identified in HCT-116 cells in which 31 metabolites were determined to be significantly regulated (p ≤ 0.05) after MB exposure. A number of key metabolites revealed by metabolomics analysis include glucose, fructose, citrate, arginine, phenylalanine, and S-adenosylhomocysteine (SAH), suggesting specific modulation of metabolism on carbohydrates, amino acids and peptides, lipids, nucleotide, cofactors and vitamins in HCT-116 CRC cells with MB treatment highly associated with apoptosis triggered by enhanced ROS and activated caspase-3. Conclusion: Our results demonstrate that MB represses CRC cell proliferation by inducing ROS-mediated apoptosis.
Macranthoidin B Modulates Key Metabolic Pathways to Enhance ROS Generation and Induce Cytotoxicity and Apoptosis in Colorectal Cancer
Xing Moreover, our recent metabolomics study on peiminine, a compound extracted from the bulbs of Fritillaria thunbergii which has been traditionally used in TCM, demonstrated inhibitory effect on CRC cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways [14] . In addition, Cui et al. [18] recently reported using LC-MS-and GC-MS-based untargeted metabolomics strategy to quantitatively evaluate the effects of Huangqin decoction on irinotecan-induced gastrointestinal toxicity, suggesting a potential application of metabolomics analysis in elucidating the comprehensive mechanisms of action of TCMs or combinations of medications.
Macranthoidin B (MB) (Fig. 1A) is a triterpenoid saponin extracted from Flos Lonicerae (Shanyinhua in Chinese), which has traditionally been used for centuries as herbal remedy for acute fever, headache, pharyngodynia, respiratory infection, pyocutaneous disease, and epidemic diseases at early stage [19] [20] [21] . In recent years, studies revealed that the extraction of saponins from Flos Lonicerae possesses protective effects on hepatic injury caused by acetaminophen and Chemokine (C-C motif) Ligand 4 (CCl 4 ) [22, 23] . However, there are limited studies reporting MB's anti-cancer effect and impact on reactive oxygen species (ROS). In this study, we attempted to demonstrate the effect of MB exposure on a typical CRC cell line, HCT-116, by inducing ROS generation via modulating key metabolic pathways. We also found significant inhibition of proliferation in cultured CRC cells and suppressed xenograft tumor growth in mice by MB. We further found that MB treatment significantly induces apoptosis by increasing superoxide and decreasing the MnSOD and GSH-Px. Taken together, our study demonstrates that MB induces ROS production, resulting in enhanced ROS-mediated apoptosis and suppressed CRC xenograft tumor growth. These findings provide a rationale for further therapeutic development of this natural product.
Materials and Methods
Cell culture HCT-116 cell line was obtained from ATCC (Manassas, VA). The cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum in a humidified incubator at 37°C in an atmosphere of 5% CO 2 . The cells were subcultured when they reached 90% confluence.
Cell viability assay
HCT-116 cells were seeded in a 96-well plate (2000 cells/well) in Dulbecco's modified Eagle's medium supplemented with 2% fetal bovine serum. MB solution (Catalog # 111814-201604; National Institutes for Food and Drug Control, Beijing, P.R. China) was applied to the cells at final concentrations of 20, 50, 100, 200, and 400 μM. To determine cell viability, 48 h after treatment, 10 μL of the ready-to-use reagent CCK-8 (catalog # DB884; Dojindo, Kumamoto, Japan) was added to each well. The cells were then incubated for approximately 30 min at 37°C in a humidified, 5% CO 2 atmosphere. Within 1 h of completion of the incubation period, absorbance of the formazan dye produced was measured at a wavelength of 450 nm using a microplate spectrometer. The measured absorbance correlated directly to the number of viable cells.
Western blot
Total cell lysate was collected and electrophoresis in 4-12% bis-acrylamide gel with 100V for 2 hours. Proteins were transfer to nitrocellulose membrane with 300 mA current for 90 minutes. Primary antibodies used for Western blot include Caspase-3 (CST, #3195), GAPDH (Abcam, ab8245), and TCF8/ZEB1 (CST, #3396).
Real-time PCR
Total RNA is isolated using RNeasy Mini Kit (Qiagen) and cDNA was prepared using SuperScript VILO™ cDNA Synthesis Kit (Invitrogen Corp., Carlsbad, CA). Real-time PCR was performed using the 7300 Real Time PCR System (Applied Biosystems, Foster City, CA) with the SYBR Premix Ex Taq (Takara Bio Inc., Shiga, Japan) ( PMID:22850540). Primers used for real-time PCR was as below: MnSOD sense: TGACCACCACCATTGAACTT; MnSOD antisense: CGTCACCGAGGAGAAGTACC; SH-Px2 sense: TTTTGGACAAGGGTGAAGGT; GSH-Px2 antisense: TGCAACCAATTTGGACATCA. Detection of ROS production Superoxide production was measured using lucigenin chemiluminescence method described previously [24] , and the emission and intensity is shown as relative light units (RLU) per milligram of protein per minute.
Flow cytometry
HCT-116 cells were treated with 200 μM of MB or dimethyl sulfoxide (control) and cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum for 24 h. The cells were collected and stained with propidium iodide and annexin V (BD Biosciences, Franklin Lakes, NJ) according to the manufacturer's guidelines and analyzed using a BD Influx flow cytometer (BD Biosciences).
Assessment of the effect of MB on xenograft tumor growth in vivo
To investigate the antitumor activity of MB in vivo, four-week nude mice, half males and half females, were injected with human CRC cells, HCT-116, and then administrated with MB or vehicle control through intraperitoneal injection respectively. Tumor volume was monitored every 7 days one week post cancer cell injection. Three week post cell injection, mice were euthanized and tumor tissues were removed and weighted.
Metabolite profiling and identification
Metabolite profiling of HCT-116 cells for MB-treated and MB-untreated group was performed using an established metabolomic profiling platform combining UPLC/LC-MS with GC-MS as previously described [14, 25, 26] . Briefly, samples were prepared with a recovery standard for QC purposes. After extraction, the samples were divided into five fractions including one for analysis by GC-MS, one for analysis by UPLC-MS/ MS with positive ion mode electrospray ionization, one for analysis by UPLC-MS/MS with negative ion mode electrospray ionization, one for LC polar platform, and one sample was reserved for backup. For GC, each sample was dried under vacuum overnight before preparation for analysis as we previously described [14] . Likewise, the samples for LC were stored overnight under nitrogen followed by further LC analysis [14] . The metabolites present in those two groups of HCT-116 cells were identified using an automated comparison with Metabolon's reference library entries [14, 25, 26] . Library matching for each metabolite was performed for each sample and corrected manually if necessary. Furthermore to ensure the highest data quality for the metabolomic data analysis, a series of quality control and curation procedures were conducted.
Data analysis
For apoptosis analysis, each cell sample was analyzed in three replicates. Data are presented as means ± standard deviations. A Welch independent sample t-test was performed to identify significant differences in apoptosis rates between the treated and untreated groups. Statistical analyses were performed using SPSS software (version 17.0; SPSS Institute, Chicago, IL). A p value equals or less than 0.05 were considered statistically significant. After data normalization, the metabolomic data were analyzed as previously reported [14, 25, 26] . First, all the metabolomic data were subjected to Multi Experiment Viewer software (version 4.8; http://www.jcvi.org/cms/research/software/) for hierarchical clustering by using the Pearson correlation coefficient. Secondly, SIMCA-P software (version 13.0; MKS Data Analytics Solutions, Malmö, Sweden) was employed to perform partial least squares discriminant analysis (PLS-DA). In the PLS-DA model, variables (metabolites) with differing importance in the project (VIP) values greater than 1 were selected for independent t-tests. Finally, variables (metabolites) with significant differences (p ≤ 0.05) in the t-test results were considered to be significantly different, which played a role on separation for the treated and untreated groups.
Results

MB induces apoptosis of CRC cells
We initially found that HCT-116 CRC cells treated with MB showed decreased cell viability in a dose-dependent manner, with accompanying morphological changes ( [3, 4, 9] . To investigate whether apoptosis induced by MB is related with ROS generation, we measured ROS product using lucigenin derived chemiluminescence. MB markedly increased the ROS products ( Fig. 2A) . Meanwhile, we found the mRNA level of both MnSOD and GSH-Px were decreased in the MB-treated cells ( Fig. 2B-C) , suggesting that increased ROS generation may be associated with a decreased level of antioxidant enzymes.
MB represses xenograft tumor growth in vivo
To investigate the antitumor activity of M in vivo, four-week nude mice were injected with HCT-116, and then administrated with macranthoidin B or vehicle control through intraperitoneal injection respectively. Tumor volume was monitored every 7 days post carcinoma cell injection. Two weeks post tumor cell injection, mice were executed and tumor tissues were removed and weighted. The result showed that the tumor size and weight of tumors from MB group were significantly lower than the control group (Fig. 3A-C) .
Lastly, immunohistochemistry of tumor tissues were performed to determine apoptosis (Fig. 5A-B) , suggesting MB induces apoptosis. Taken together, these results demonstrate that MB-mediated tumor growth inhibition is associated with apoptosis.
Metabolic characterization of HCT-116 cells
In this study, by taking advantage of an established global metabolic profiling approach that combined GC-MS with UPLC/MS-MS [14] , we comprehensively uncovered the metabolic profiles of HCT-116 cells with MB exposure. Totally 236 named metabolites were identified in HCT-116 cells before and after MB treatment. These metabolites were mapped to all the eight central pathways including 60 amino acids, 25 carbohydrates, 15 co-factors or vitamins, 81 lipids, 24 nucleotides, 16 peptides, 7 xenobiotics, and 8 metabolites involved in energy metabolism. As compared with previous studies, these findings uncover a much broader metabolome for HCT-116 cells and provide abundant data for the determination of metabolic alteration induced by MB [14, 27, 28] .
Metabolic alteration in HCT-116 cells after MB exposure
To review the similarities and differences of the identified metabolites between MB -treated and untreated HCT-116 cells, hierarchical cluster analysis was employed for all samples (Fig. 6) . The heat map revealed remarkable variation between two groups, each 
replicates. Intriguingly, the 236 identified metabolites differed markedly between the MB-treated and untreated groups. In most cases, MB reduces the metabolites that were highly abundant in untreated HCT-116 cells and increases the metabolites that were at low levels in untreated cells. For example, the levels of ethanolamine in the MBtreated group were higher than those in the untreated group, but S-adenosylhomocysteine (SAH) was more abundant in the untreated group than in the MB-treated group. To further determine the metabolic alteration in HCT-116 cells induced by MB treatment, a supervised statistical method of PLS-DA was employed. PLS-DA is a powerful method for compositional (metabolic) data that contains more metabolites (in hundreds) than biological materials (only tens) [29] . The results showed that levels of 31 metabolites (Table  1 ; Fig. 7A-B) were significantly different between the two groups (p ≤ 0.05). Meanwhile, these 31 metabolites included 21 increased and 10 decreased metabolites covered all the eight major pathways, with the magnitude of the changes ranging from 0.35-to 4.95-fold. As shown in Table 1 , the concentrations of 6 nucleotides, 2 amino acids, 1 peptide, and 1 lipid were decreased after MB exposure. Meanwhile, the levels of 3 co-factors or vitamins, 4 carbohydrates, 2 amino acids, 2 peptides, 7 lipids and citrate were increased after the treatment. The results here suggest remarkable metabolic alteration involved in colorectal cell metabolism including amino acid metabolism, carbohydrate metabolism, and lipid metabolism.
Metabolic network in MB-treated cells
To fully reveal the regulatory network of 31 changed metabolites in MB-treated cells, we build up a metabolic network for amino acids and peptides, carbohydrates, lipids, nucleotides, cofactors and vitamins metabolism and xenobiotics. As shown in Fig. 8, 5 metabolites (glucose, fructose, 3-phosphoglycerate, 2-phosphoglycerate, and citrate) in carbohydrate metabolism displayed elevation in MB-treated HCT-116 cells. While in the metabolism of amino acid and peptide, the levels of four amino acids and three peptides displayed significantly nucleotide metabolism were significantly decreased, which included AMP, IMP, 5'-GMP, 5'-CMP, pseudouridine, and adenine. In addition, there were 5 significantly increased metabolites participated in cofactor and vitamin metabolism, and xenobiotics metabolism: NaMN, nicotinate ribonucleoside, nicotinamide riboside, phenol red, and erythritol. 
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Discussion
To comprehensively elucidate the anti-tumor mechanism of MB, here for the first time we employed an established non-targeted metabolomic analysis platform that combined UPLC/MS-MS with GC-MS to profile HCT-116 cells treated with MB. Totally 236 known metabolites were determined in HCT-116 cells, which were mapped to most of the central metabolism pathways including amino acid super pathway, carbohydrate super pathway, lipid super pathway, and nucleotide super pathway. The results thus far uncover a much broader metabolome, manifesting the power of this untargeted metabolomic profiling platform in elucidating metabolic characterization of HCT-116 cells [14, 27, 28] . More importantly, significant metabolic alterations in HCT-116 cells after MB treatment were identified, including changes of several important metabolites and related pathways. These metabolic changes in response to MB may play important roles in repressing tumor progression and inducing apoptosis in CRC cells. The results here provide new insights into metabolic changes and regulatory aspects of the metabolic pathways associated with antitumor mechanism of MB.
Cancer cells usually exhibit an altered metabolic pattern to support the proliferation and tumor growth [30] . In our study, several important metabolites and key metabolic pathways were modulated in HCT-116 cells with MB exposure. For example, cancer cells generally exhibit increased glycolysis for ATP generation (the Warburg effect) due in part to mitochondrial respiration injury and hypoxia, which are frequently associated with resistance to therapeutic agents [31] . In line with the literature, significant alteration of some of the glycolytic intermediates was noted in cells treated with MB compared to untreated control cells, which may be an indication of increased glucose uptake and potential alteration in glycolysis within the cells treated with MB [14] . Moreover, a significant increase in most of the glycolytic intermediates including glucose, fructose, citrate, 3-phosphoglycerate and 2-phosphoglycerate was displayed in cells treated with MB, suggesting alteration in glycolytic energy metabolism in cancer cells by MB. Especially, the convert of 3-phosphoglycerate to 2-phosphoglycerate (2-PG), catalyzed by phosphoglycerate mutase (PGAM), is commonly upregulated in many human cancers and plays an important role in cancer metabolism [32] . Besides, increased glutamine metabolism is another commonly metabolic alteration observed in cancer cells, supporting cell growth [14] . Although both the concentrations of glutamine and glutamate did not change, the level of one related peptide, γ-glutamylglutamate showed significantly decreased. Furthermore, HCT-116 cells treated with MB exhibited significant changes of other 6 metabolites (arginine, phenylalanine, and SAH) involved in the metabolism of amino acid and peptide, which plays important roles in colorectal cancer development and progression. For example, the level of arginine in MB-treated HCT-116 cells was significantly decreased, which probably resulted from the treatment by MB. Accumulating evidence has shown the contributions made to inhibit this pathway for cancer treatment, since overactive arginine catabolism may be a common phenomenon in cancer development and progression [33] . As reported, arginine is synthesized from glutamate via the intestinal-renal axis in humans but glutamate was determined to be unchanged. Notably, the decrease in SAH levels identified in MB-treated cells may indicate the inhibition of CRC cell proliferation, since accumulation of SAH in body fluids was reported to be associated with vascular disease and CRC [34, 35] . The level of three metabolites related to pyruvate was all upregulated in MB-treated HCT-116 cells including phenylalanine. High level of phenylalanine may indicate a higher protein degradation rate [36] . The other increased metabolite was 2-aminobutyrate, which was determined to be one of specific bioindicators in colorectal cancer patients [37] . Likewise, remarkable metabolic changes related to lipid metabolism were also observed, including 8 lipids and their corresponding metabolic pathways. Among them, sphinganine may potentiate apoptosis in HCT-116 cells after MB exposure [38] . Likewise, cholestanol was reported with CRC progression via activation of ROS [39] , and high level of cholestanol might be associated with apoptosis in HCT-116 cells, since it is a marker of cholesterol absorption, which was reported to cause endoplasmic reticulum stress-induced apoptosis [40] . The results here also revealed an alteration of nucleotide metabolism associated with AMP, IMP, 5'-GMP, 5'-CMP, and pseudouridine, which are necessary for a number of key cellular processes, and imbalance in their levels lead to tumor progression [41] . AMPK is a key regulator of metabolism and can negatively regulate tumor proliferation, which functions as a cellular energy sensor primarily regulated by AMP [42] . Another nucleotide, pseudouridine, was reported to be a putative marker in various types of cancer and heart failure [43] . Additionally, several cofactors and vitamins including nicotinamide riboside, NaMN, and nicotinate ribonucleoside were accumulated in MB-treated cells. These metabolites were participated in the NAD metabolome that was reported to be a key determinant of cancer cell growth. High level of nicotinamide riboside, the NAD + precursor may lead to more active oxidative metabolism in MB-treated HCT-116 cells [44] . Taken together, the metabolic alterations in treated cells indicate an important role of MB in suppressing CRC cell proliferation, inducing apoptosis, and inhibiting tumor progression. It was further validated in in vivo experiments that MB can actually reduce CRC xenograft tumor growth.
Apoptosis is deregulated in multiple cancer types, making eradication of cancer cells a difficult challenge [45] . Consequently, anti-cancer agents or other therapies that promote apoptosis are under development as alternative strategy in cancer therapy discovery. To date, most of phytochemical compounds originated from TCM have been identified based on their activity on inducing apoptosis in cancer cells [46] [47] [48] . For example, Berberine, a wellknown TCM compound initially extracted from the herb Huanglian (Coptis chinensis) has been shown to induce ROS-mediated apoptosis in various cancers [49] . Levistolide A (LA), a natural compound isolated from the traditional Chinese herb Ligusticum chuanxiong Hort, was found induce apoptosis of colon cancer cells via ROS-mediated ER stress pathway [50] . In present study, MB, also isolated from the Flos Lonicerae (Shanyinhua in Chinese), was demonstrated to promote apoptosis in a dose-dependent manner. In addition to modulate glucose and glutamine metabolism, MB was found to significantly impact several important apoptosis-related metabolites such as sphinganine and cholestanol in HCT-116 cells [51] . Generation of ROS plays an important role in the mitochondria-mediated intrinsic apoptotic pathway, which is regulated by oxidative stress response mechanism [52] . Our study showed a significant decrease of SAH level in CRC cells treated with MB suggests an enhanced generation of ROS, since SAH functions as a major cellular anti-oxidant [53] . Moreover, level of γ-glutamylglutamate was decreased, reflecting the changes associated with a key survival antioxidant, glutathione. It is believed that caspase-3 is the primary executioner of apoptosis [54] . As a result, we also evaluated alteration of caspase-3 protein, and we found high levels of caspase-3 in MB-treated CRC cells. These results suggest that MB induces apoptosis in HCT-116 cells by promoting the generation of ROS and the activation of caspase-3.
In the present study, we, for the first time, revealed the anti-tumor mechanism of MB, extracted from the Flos Lonicerae. Our results show remarkable metabolic alterations of differential metabolite production and activation of metabolic pathways in HCT-116 CRC cells with MB treatment, eventually leading to induced apoptosis through enhanced ROS production and activated caspase-3. This study provides new insights into of the mechanisms by which MB suppresses CRC growth and progression, supporting its potential implication in future development for treating CRC. We are currently identifying whether there is mitochondrial dysfunction including the determination of mitochondrial membrane potential and ROS generation. The expression of apoptosis-related genes such as Bax and Bcl-2 are also under investigation in HCT-116 CRC cells with MB treatment. Moreover, proteomics and transcriptomics analyses are to be employed to explore and validate the anti-tumor mechanisms of MB, in addition to evaluating the usefulness of MB as a novel anticancer therapy for CRC and other cancer types.
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